Hard Problems Need "Soft" Science: Integrating Quality of Life into Treatment Decision Making

APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer Trial.

JCO precision oncology·2026

Evaluating safety: Number needed to harm analyses of androgen receptor inhibitors in advanced prostate cancer.

European journal of cancer (Oxford, England : 1990)·2026

Long-term oncological outcomes from a prospective cohort of patients with localised prostate cancer.

BJU international·2026

Recruitment strategies in the PROMISE Registry: Evaluating institutional outreach, direct-to-patient marketing, and community engagement approaches in a decentralized germline genetic registry.

Contemporary clinical trials communications·2026

Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.

JCO precision oncology·2026

Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.

European journal of cancer (Oxford, England : 1990)·2026

Why Look Further When the Solution Is in Front of You - or Is It? The Value of Confirmatory PSA in Prostate Cancer Screening.

European urology·2026

Darolutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase 3 ARANOTE Trial.

European urology·2026

Hereditary Renal Cancer Syndromes: Redefining Clinical Management in the Era of Precision Medicine.

European urology·2026

PSMA Radio-guided Surgery to Identify Lymph Node Metastases in Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Phase 2 Prospective Study.

European urology·2026

EORTC 2238 DE-ESCALATE: Revisiting Intermittent Maximal Androgen Blockade in Metastatic Hormone-sensitive Prostate Cancer.

European urology·2026

Healthcare professionals' readiness and perceived barriers to drone-assisted emergency healthcare in Palestine.

Digital health·2026

Validity and reliability of measures of burnout, resilience, leadership and interprofessional relationships in a Frontline Healthcare Workers Crisis Survey (FHWCS) and Healthcare Leaders Crisis Survey (HLCS).

Journal of health organization and management·2026

'It's about demonstrating the impact and effectiveness of the work we do.' Results of a survey to measure the research capacity of a community-based health and social service.

Australian journal of primary health·2026

Effective Organizational Leadership.

Dermatologic clinics·2026

How organizational conditions shape development and assessment of patient-Centered lifestyle interventions targeting hard-to-reach patients with cardiac disease or type 2 diabetes.

Chronic illness·2026

Patient-Oriented Digital Health Intervention for Chronic Kidney Disease: From Evidence to Everyday Care.

Journal of medical Internet research·2026

Related Experiment Videos

Hard Problems Need "Soft" Science: Integrating Quality of Life into Treatment Decision Making

Related Concept Videos

APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer Trial.

Evaluating safety: Number needed to harm analyses of androgen receptor inhibitors in advanced prostate cancer.

Long-term oncological outcomes from a prospective cohort of patients with localised prostate cancer.

Recruitment strategies in the PROMISE Registry: Evaluating institutional outreach, direct-to-patient marketing, and community engagement approaches in a decentralized germline genetic registry.

Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.

Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.

Why Look Further When the Solution Is in Front of You - or Is It? The Value of Confirmatory PSA in Prostate Cancer Screening.

Darolutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase 3 ARANOTE Trial.

Hereditary Renal Cancer Syndromes: Redefining Clinical Management in the Era of Precision Medicine.

PSMA Radio-guided Surgery to Identify Lymph Node Metastases in Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Phase 2 Prospective Study.

EORTC 2238 DE-ESCALATE: Revisiting Intermittent Maximal Androgen Blockade in Metastatic Hormone-sensitive Prostate Cancer.

Healthcare professionals' readiness and perceived barriers to drone-assisted emergency healthcare in Palestine.

Validity and reliability of measures of burnout, resilience, leadership and interprofessional relationships in a Frontline Healthcare Workers Crisis Survey (FHWCS) and Healthcare Leaders Crisis Survey (HLCS).

'It's about demonstrating the impact and effectiveness of the work we do.' Results of a survey to measure the research capacity of a community-based health and social service.

Effective Organizational Leadership.

How organizational conditions shape development and assessment of patient-Centered lifestyle interventions targeting hard-to-reach patients with cardiac disease or type 2 diabetes.

Patient-Oriented Digital Health Intervention for Chronic Kidney Disease: From Evidence to Everyday Care.

Related Experiment Videos

Hard Problems Need "Soft" Science: Integrating Quality of Life into Treatment Decision Making

Related Concept Videos

Related Articles